---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.__)

 

Filed by the Registrant	☑
Filed by a Party other than the Registrant	☐

        

Check the appropriate box:

 

☐         Preliminary Proxy Statement

☐         Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐         Definitive Proxy Statement

☑         Definitive Additional Materials

☐         Soliciting Material Pursuant to § 240.14a-12

 

ACELRX PHARMACEUTICALS, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box)

 

☑         No fee required.

☐         Fee paid previously with preliminary materials.

☐         Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.